Distinct human antibody response to the biological warfare agent Burkholderia mallei.
The genetic similarity between Burkholderia mallei (glanders) and Burkholderia pseudomallei (melioidosis) had led to the general assumption that pathogenesis of each bacterium would be similar. In 2000, the first human case of glanders in North America since 1945 was reported in a microbiology laboratory worker. Leveraging the availability of pre-exposure sera for this individual and employing the same well-characterized protein array platform that has been previously used to study a large cohort of melioidosis patients in southeast Asia, we describe the antibody response in a human with glanders. Analysis of 156 peptides present on the array revealed antibodies against 17 peptides with a > 2-fold increase in this infection. Unexpectedly, when the glanders data were compared with a previous data set from B. pseudomallei infections, there were only two highly increased antibodies shared between these two infections. These findings have implications in the diagnosis and treatment of B. mallei and B. pseudomallei infections.
University of Virginia, Charlottesville, VA, USA.
John J
JJ
Varga
Adam
A
Vigil
David
D
DeShazer
David M
DM
Waag
Philip
P
Felgner
Joanna B
JB
Goldberg
D000907:Antibodies, Bacterial / Q000276:immunology*; D000917:Antibody Formation / Q000276:immunology*; D001426:Bacterial Proteins / Q000276:immunology*; D054045:Biological Warfare Agents; D042726:Burkholderia mallei / Q000276:immunology*; D016957:Burkholderia pseudomallei / Q000276:immunology; D005896:Glanders / Q000175:diagnosis / Q000276:immunology* / Q000382:microbiology; D006801:Humans
D000907:Antibodies, Bacterial; D001426:Bacterial Proteins; D054045:Biological Warfare Agents